| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | Jan 23, 2024 | Sale | $9.07 | 1,559 | 14,138 | 78,698 | Jan 25, 2024, 04:10 PM | |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Oct 03, 2023 | Sale | $8.25 | 3,091 | 25,504 | 80,257 | Oct 04, 2023, 04:05 PM | |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Feb 01, 2023 | Sale | $21.75 | 1,779 | 38,697 | 82,069 | Feb 02, 2023, 07:04 PM | |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Jan 24, 2023 | Sale | $21.90 | 1,550 | 33,952 | 63,598 | Jan 26, 2023, 04:05 PM | |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Oct 04, 2022 | Sale | $25.68 | 3,042 | 78,119 | 65,148 | Oct 06, 2022, 08:10 PM | |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Jan 31, 2022 | Sale | $27.40 | 1,125 | 30,825 | 67,297 | Feb 02, 2022, 04:18 PM | |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Jan 24, 2022 | Sale | $24.98 | 1,875 | 46,837 | 58,582 | Jan 26, 2022, 04:36 PM | |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Oct 04, 2021 | Sale | $24.77 | 3,058 | 75,746 | 60,457 | Oct 05, 2021, 04:06 PM | |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,086 | 63,515 | Aug 17, 2021, 07:41 PM | |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Feb 08, 2021 | Sale | $31.58 | 1,125 | 35,527 | 59,344 | Feb 09, 2021, 04:31 PM | |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Feb 05, 2021 | Sale | $31.41 | 1,125 | 35,336 | 60,469 | Feb 09, 2021, 04:31 PM | |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Feb 02, 2021 | Sale | $30.75 | 563 | 17,312 | 57,657 | Feb 03, 2021, 09:33 PM | |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Feb 03, 2021 | Sale | $28.91 | 563 | 16,276 | 57,094 | Feb 03, 2021, 09:33 PM | |
| RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Officer | Oct 02, 2020 | Sale | $18.90 | 2,188 | 41,353 | 44,517 | Oct 05, 2020, 08:31 PM | |
| RTRX | Retrophin, Inc. | Heerma Peter | Chief Commercial Officer | Oct 05, 2020 | Sale | $19.35 | 2,188 | 42,338 | 42,329 | Oct 05, 2020, 08:31 PM |
Menu